Literature DB >> 29629495

Lewy Body Disease: Clinical and Pathological "Overlap Syndrome" Between Synucleinopathies (Parkinson Disease) and Tauopathies (Alzheimer Disease).

Clovis Foguem1,2, Patrick Manckoundia3,4.   

Abstract

Lewy body disease (LBD) is a neurodegenerative disease resulting in dementia. It shares clinical and pathological features with Parkinson disease (PD), the most frequent synucleinopathy, Parkinson disease dementia (PDD), and Alzheimer disease (AD), a tauopathy. Even though the diagnostic criteria for these neurodegenerative diseases are clearly established, and recently revised for LBD, their precise clinical diagnosis is often difficult because LBD, PD, PDD, and AD share epidemiological, clinical, and pathological characteristics. This manuscript discusses current understanding of overlapping symptoms and the particular features of LBD, PD, and AD. It also describes features that could facilitate the diagnosis of each of these diseases. We concluded that the concept of neurodegenerative "overlap" syndrome, which includes the accepted diagnosis of LBD, may be taken in account and should contribute to clarifying LBD and definitions of close differential diagnoses. This should allow clinicians to suspect LBD at an earlier stage and provide better patient care.

Entities:  

Keywords:  Alzheimer disease; Lewy body disease; Overlapping syndrome; Parkinson disease

Mesh:

Substances:

Year:  2018        PMID: 29629495     DOI: 10.1007/s11910-018-0835-5

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  44 in total

1.  α-Synuclein strains cause distinct synucleinopathies after local and systemic administration.

Authors:  W Peelaerts; L Bousset; A Van der Perren; A Moskalyuk; R Pulizzi; M Giugliano; C Van den Haute; R Melki; V Baekelandt
Journal:  Nature       Date:  2015-06-10       Impact factor: 49.962

Review 2.  How to diagnose dementia with Lewy bodies: state of the art.

Authors:  Felix Geser; Gregor K Wenning; Werner Poewe; Ian McKeith
Journal:  Mov Disord       Date:  2005-08       Impact factor: 10.338

3.  The cognitive profile and CSF biomarkers in dementia with Lewy bodies and Parkinson's disease dementia.

Authors:  M Andersson; H Zetterberg; L Minthon; K Blennow; E Londos
Journal:  Int J Geriatr Psychiatry       Date:  2011-01       Impact factor: 3.485

4.  Neural correlates of psychotic symptoms in dementia with Lewy bodies.

Authors:  Yasuhiro Nagahama; Tomoko Okina; Norio Suzuki; Minoru Matsuda
Journal:  Brain       Date:  2009-11-17       Impact factor: 13.501

5.  Comparison of dementia with Lewy bodies to Alzheimer's disease and Parkinson's disease with dementia.

Authors:  Enrique Noe; Karen Marder; Karen L Bell; Diane M Jacobs; Jennifer J Manly; Yaakov Stern
Journal:  Mov Disord       Date:  2004-01       Impact factor: 10.338

Review 6.  [Changes in olfaction during ageing and in certain neurodegenerative diseases: up-to-date].

Authors:  A-J Bianchi; H Guépet-Sordet; P Manckoundia
Journal:  Rev Med Interne       Date:  2014-10-07       Impact factor: 0.728

Review 7.  Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.

Authors:  Michal Rolinski; Chris Fox; Ian Maidment; Rupert McShane
Journal:  Cochrane Database Syst Rev       Date:  2012-03-14

Review 8.  Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.

Authors:  Ian G McKeith; Bradley F Boeve; Dennis W Dickson; Glenda Halliday; John-Paul Taylor; Daniel Weintraub; Dag Aarsland; James Galvin; Johannes Attems; Clive G Ballard; Ashley Bayston; Thomas G Beach; Frédéric Blanc; Nicolaas Bohnen; Laura Bonanni; Jose Bras; Patrik Brundin; David Burn; Alice Chen-Plotkin; John E Duda; Omar El-Agnaf; Howard Feldman; Tanis J Ferman; Dominic Ffytche; Hiroshige Fujishiro; Douglas Galasko; Jennifer G Goldman; Stephen N Gomperts; Neill R Graff-Radford; Lawrence S Honig; Alex Iranzo; Kejal Kantarci; Daniel Kaufer; Walter Kukull; Virginia M Y Lee; James B Leverenz; Simon Lewis; Carol Lippa; Angela Lunde; Mario Masellis; Eliezer Masliah; Pamela McLean; Brit Mollenhauer; Thomas J Montine; Emilio Moreno; Etsuro Mori; Melissa Murray; John T O'Brien; Sotoshi Orimo; Ronald B Postuma; Shankar Ramaswamy; Owen A Ross; David P Salmon; Andrew Singleton; Angela Taylor; Alan Thomas; Pietro Tiraboschi; Jon B Toledo; John Q Trojanowski; Debby Tsuang; Zuzana Walker; Masahito Yamada; Kenji Kosaka
Journal:  Neurology       Date:  2017-06-07       Impact factor: 9.910

Review 9.  Dementia with Lewy bodies.

Authors:  David Weisman; Ian McKeith
Journal:  Semin Neurol       Date:  2007-02       Impact factor: 3.420

10.  Interleukin-1 mediates Alzheimer and Lewy body pathologies.

Authors:  W Sue T Griffin; Ling Liu; Yuekui Li; Robert E Mrak; Steven W Barger
Journal:  J Neuroinflammation       Date:  2006-03-16       Impact factor: 8.322

View more
  12 in total

Review 1.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-18       Impact factor: 3.575

2.  Altered hydroxymethylome in the substantia nigra of Parkinson's disease.

Authors:  Shishi Min; Qian Xu; Lixia Qin; Yujing Li; Ziyi Li; Chao Chen; Hao Wu; Junhai Han; Xiongwei Zhu; Peng Jin; Beisha Tang
Journal:  Hum Mol Genet       Date:  2022-10-10       Impact factor: 5.121

Review 3.  State-of-the-Art Methods and Emerging Fluid Biomarkers in the Diagnostics of Dementia-A Short Review and Diagnostic Algorithm.

Authors:  Eino Solje; Alberto Benussi; Emanuele Buratti; Anne M Remes; Annakaisa Haapasalo; Barbara Borroni
Journal:  Diagnostics (Basel)       Date:  2021-04-27

4.  Visual hallucinations in Lewy body disease: pathophysiological insights from phenomenology.

Authors:  Fabrizia D'Antonio; Maddalena Boccia; Antonella Di Vita; Antonio Suppa; Andrea Fabbrini; Marco Canevelli; Francesca Caramia; Marco Fiorelli; Cecilia Guariglia; Stefano Ferracuti; Carlo de Lena; Dag Aarsland; Dominic Ffytche
Journal:  J Neurol       Date:  2022-01-31       Impact factor: 6.682

Review 5.  Evaluating the Remote Control of Programmed Cell Death, with or without a Compensatory Cell Proliferation.

Authors:  Xixi Dou; Lichan Chen; Mingjuan Lei; Lucas Zellmer; Qingwen Jia; Peixue Ling; Yan He; Wenxiu Yang; Dezhong Joshua Liao
Journal:  Int J Biol Sci       Date:  2018-10-19       Impact factor: 6.580

Review 6.  Lewy body disease or diseases with Lewy bodies?

Authors:  Kateřina Menšíková; Radoslav Matěj; Carlo Colosimo; Raymond Rosales; Lucie Tučková; Jiří Ehrmann; Dominik Hraboš; Kristýna Kolaříková; Radek Vodička; Radek Vrtěl; Martin Procházka; Martin Nevrlý; Michaela Kaiserová; Sandra Kurčová; Pavel Otruba; Petr Kaňovský
Journal:  NPJ Parkinsons Dis       Date:  2022-01-10

7.  Orexin-A in Patients With Lewy Body Disease: A Systematic Review and Meta-Analysis.

Authors:  Jinghuan Gan; Zhichao Chen; Jiuyan Han; Lingyun Ma; Shuai Liu; Xiao-Dan Wang; Yong Ji
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-17       Impact factor: 5.555

Review 8.  Computational Approaches for Supporting Combination Therapy in the Post-Aducanumab Era in Alzheimer's Disease.

Authors:  Hugo Geerts; Piet van der Graaf
Journal:  J Alzheimers Dis Rep       Date:  2021-11-23

9.  Role of Alterations in Protein Kinase p38γ in the Pathogenesis of the Synaptic Pathology in Dementia With Lewy Bodies and α-Synuclein Transgenic Models.

Authors:  Michiyo Iba; Changyoun Kim; Jazmin Florio; Michael Mante; Anthony Adame; Edward Rockenstein; Somin Kwon; Robert Rissman; Eliezer Masliah
Journal:  Front Neurosci       Date:  2020-03-31       Impact factor: 4.677

10.  Use of Patient-Reported Symptoms from an Online Symptom Tracking Tool for Dementia Severity Staging: Development and Validation of a Machine Learning Approach.

Authors:  Aaqib Shehzad; Kenneth Rockwood; Justin Stanley; Taylor Dunn; Susan E Howlett
Journal:  J Med Internet Res       Date:  2020-11-11       Impact factor: 5.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.